PT  - JOURNAL ARTICLE
AU  - Waters, Richard C.
AU  - Mugleston, Meaghan
AU  - Terry, Anina
AU  - Reinhart, Carrie
AU  - Wilson, Megan
TI  - Nurse Standing Orders for Buprenorphine Follow-Up Care in a Community Health Center Network
AID  - 10.3122/jabfm.2022.220426R1
DP  - 2023 Oct 11
TA  - The Journal of the American Board of Family
                Medicine
PG  - 723--730
VI  - 36
IP  - 5
4099  - http://www.jabfm.org/content/36/5/723.short
4100  - http://www.jabfm.org/content/36/5/723.full
SO  - J Am Board Fam Med2023 Oct 11; 36
AB  - Background: Less than 20% of individuals with opioid use disorder (OUD) are receiving a medication treatment for OUD in the United States. Though nurses can assume critical roles in outpatient models of OUD care, there are no published reports of buprenorphine standing orders for nurses that guide a nuanced response for patients returning as expected versus those re-engaging after a treatment lapse, without requiring real-time prescriber consultation.Methods: Standing orders for buprenorphine were created with multiple stakeholders within an urban community health center that includes traditional clinics as well as non-traditional homeless care sites. After more than two years of use, an anonymous survey assessed staff perception of usability and safety of the standing orders using the validated system usability scale (SUS) and a 5-item Likert scale. Patient retention rates at 12 and 18 months were compared for sites that were early- and late-adopters of the standing orders.Results: Of 24 clinicians and 7 nurses who responded to the survey, 46% had used the standing orders. More than 85% reported a perception that the standing orders improved team-based care and increased access to buprenorphine refills. None reported any safety concerns. The median SUS score was 75.0 (SD 15.4), rated as “excellent”. There was no statistically significant difference in 12- or 18-month retention rates between early- and late-adopter sites of the standing orders.Conclusions: Nurse standing orders for buprenorphine follow-up and re-engagement care are feasible, usable and perceived as safe in varied community health center settings.